Delayed or Immediate Local Treatment of Veins

NCT ID: NCT03340246

Last Updated: 2022-08-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

140 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-05-04

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Varicose veins affect a majority of adult patients and cause a decreased quality of life. In recent years, standard practice has been to perform thermoablation and local phlebectomies in the same procedure. There is conflicting data on the long-term outcome of the local varicose veins; there seems to be a need for more re-interventions if the local varicosities are not treated immediately. On the other hand, the prolonged combined procedure increases procedural pain and bleeding, as well as the risk for complications from deep vein thrombosis/pulmonary embolism.

This trial aims to evaluate the need for immediate treatment of local varicosities and the potential sufficiency of main trunk treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Varicose Veins Leg

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Immediate phlebectomy

Mechanochemical ablation of main trunk and immediate phlebectomy of varicosities

Group Type ACTIVE_COMPARATOR

Immediate phlebectomy

Intervention Type PROCEDURE

See arm description

Delayed treatment

Mechanochemical ablation of main trunk. Evaluation of varicosities at 3 months with sclerotherapy if required

Group Type EXPERIMENTAL

Delayed sclerotherapy

Intervention Type PROCEDURE

See arm descriptions

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Delayed sclerotherapy

See arm descriptions

Intervention Type PROCEDURE

Immediate phlebectomy

See arm description

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ultrasound verified insufficiency of great saphenous vein (GSV)
* GSV diameter 5-10 mm
* C2-C4 varicosities
* Most proximal insufficient branch in the distal thigh
* Written and signed informed consent

Exclusion Criteria

* Peripheral arterial disease
* Body mass index \>40
* Lymphoedema
* Known allergy to sclerosant
* Any known coagulopathy or history of deep vein thrombosis
* Severe illness
* Pregnancy
Minimum Eligible Age

20 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Helsinki University Central Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Maarit Venermo

Professor of Vascular Surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Karoliina Halmesmäki, M.D., Ph.D

Role: PRINCIPAL_INVESTIGATOR

Helsinki University Central Hospital

Maarit Venermo, M.D., Ph.D.

Role: STUDY_DIRECTOR

Helsinki University Central Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Helsinki University Hospital

Helsinki, , Finland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Finland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DELICATVE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.